173 related articles for article (PubMed ID: 35970273)
1. Craniofacial and dental phenotype of two girls with osteogenesis imperfecta due to mutations in CRTAP.
Marulanda J; Ludwig K; Glorieux F; Lee B; Sutton VR; ; Retrouvey JM; Rauch F
Bone; 2022 Nov; 164():116516. PubMed ID: 35970273
[TBL] [Abstract][Full Text] [Related]
2. Dental and craniofacial defects in the Crtap
Xu H; Lenhart SA; Chu EY; Chavez MB; Wimer HF; Dimori M; Somerman MJ; Morello R; Foster BL; Hatch NE
Dev Dyn; 2020 Jul; 249(7):884-897. PubMed ID: 32133710
[TBL] [Abstract][Full Text] [Related]
3. Genetic Analysis, Phenotypic Spectrum and Functional Study of Rare Osteogenesis Imperfecta Caused by CRTAP Variants.
Zhou B; Gao P; Hu J; Lin X; Sun L; Zhang Q; Jiang Y; Wang O; Xia W; Xing X; Li M
J Clin Endocrinol Metab; 2024 Jun; 109(7):1803-1813. PubMed ID: 38214665
[TBL] [Abstract][Full Text] [Related]
4. Oro-dental and cranio-facial characteristics of osteogenesis imperfecta type V.
Retrouvey JM; Taqi D; Tamimi F; Dagdeviren D; Glorieux FH; Lee B; Hazboun R; Krakow D; Sutton VR;
Eur J Med Genet; 2019 Dec; 62(12):103606. PubMed ID: 30593885
[TBL] [Abstract][Full Text] [Related]
5. Severe osteogenesis imperfecta caused by a small in-frame deletion in CRTAP.
Amor IM; Rauch F; Gruenwald K; Weis M; Eyre DR; Roughley P; Glorieux FH; Morello R
Am J Med Genet A; 2011 Nov; 155A(11):2865-70. PubMed ID: 21964860
[TBL] [Abstract][Full Text] [Related]
6. Deep intronic mutation in CRTAP results in unstable isoforms of the protein to induce type I collagen aggregation in a lethal type of osteogenesis imperfecta type VII.
Udupa P; Shrikondawar AN; Nayak SS; Shah H; Ranjan A; Girisha KM; Bhavani GS; Ghosh DK
Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166741. PubMed ID: 37146916
[TBL] [Abstract][Full Text] [Related]
7. Sclerostin Antibody Treatment Improves the Bone Phenotype of Crtap(-/-) Mice, a Model of Recessive Osteogenesis Imperfecta.
Grafe I; Alexander S; Yang T; Lietman C; Homan EP; Munivez E; Chen Y; Jiang MM; Bertin T; Dawson B; Asuncion F; Ke HZ; Ominsky MS; Lee B
J Bone Miner Res; 2016 May; 31(5):1030-40. PubMed ID: 26716893
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of CRTAP in non-lethal recessive osteogenesis imperfecta reduces collagen deposition into matrix.
Valli M; Barnes AM; Gallanti A; Cabral WA; Viglio S; Weis MA; Makareeva E; Eyre D; Leikin S; Antoniazzi F; Marini JC; Mottes M
Clin Genet; 2012 Nov; 82(5):453-9. PubMed ID: 21955071
[TBL] [Abstract][Full Text] [Related]
9. Severe osteogenesis imperfecta in cyclophilin B-deficient mice.
Choi JW; Sutor SL; Lindquist L; Evans GL; Madden BJ; Bergen HR; Hefferan TE; Yaszemski MJ; Bram RJ
PLoS Genet; 2009 Dec; 5(12):e1000750. PubMed ID: 19997487
[TBL] [Abstract][Full Text] [Related]
10. CRTAP mutations in lethal and severe osteogenesis imperfecta: the importance of combining biochemical and molecular genetic analysis.
Van Dijk FS; Nesbitt IM; Nikkels PG; Dalton A; Bongers EM; van de Kamp JM; Hilhorst-Hofstee Y; Den Hollander NS; Lachmeijer AM; Marcelis CL; Tan-Sindhunata GM; van Rijn RR; Meijers-Heijboer H; Cobben JM; Pals G
Eur J Hum Genet; 2009 Dec; 17(12):1560-9. PubMed ID: 19550437
[TBL] [Abstract][Full Text] [Related]
11. Mutational characterization of the P3H1/CRTAP/CypB complex in recessive osteogenesis imperfecta.
Barbirato C; Trancozo M; Almeida MG; Almeida LS; Santos TO; Duarte JC; Rebouças MR; Sipolatti V; Nunes VR; Paula F
Genet Mol Res; 2015 Dec; 14(4):15848-58. PubMed ID: 26634552
[TBL] [Abstract][Full Text] [Related]
12. Tendon and motor phenotypes in the
Grol MW; Haelterman NA; Lim J; Munivez EM; Archer M; Hudson DM; Tufa SF; Keene DR; Lei K; Park D; Kuzawa CD; Ambrose CG; Eyre DR; Lee BH
Elife; 2021 May; 10():. PubMed ID: 34036937
[TBL] [Abstract][Full Text] [Related]
13. Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta.
Marini JC; Cabral WA; Barnes AM
Cell Tissue Res; 2010 Jan; 339(1):59-70. PubMed ID: 19862557
[TBL] [Abstract][Full Text] [Related]
14. Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes.
Pyott SM; Schwarze U; Christiansen HE; Pepin MG; Leistritz DF; Dineen R; Harris C; Burton BK; Angle B; Kim K; Sussman MD; Weis M; Eyre DR; Russell DW; McCarthy KJ; Steiner RD; Byers PH
Hum Mol Genet; 2011 Apr; 20(8):1595-609. PubMed ID: 21282188
[TBL] [Abstract][Full Text] [Related]
15. Dental and craniofacial characteristics caused by the p.Ser40Leu mutation in IFITM5.
Dagdeviren D; Tamimi F; Lee B; Sutton R; Rauch F; Retrouvey JM
Am J Med Genet A; 2019 Jan; 179(1):65-70. PubMed ID: 30289614
[TBL] [Abstract][Full Text] [Related]
16. CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII.
Fratzl-Zelman N; Morello R; Lee B; Rauch F; Glorieux FH; Misof BM; Klaushofer K; Roschger P
Bone; 2010 Mar; 46(3):820-6. PubMed ID: 19895918
[TBL] [Abstract][Full Text] [Related]
17. CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta.
Baldridge D; Schwarze U; Morello R; Lennington J; Bertin TK; Pace JM; Pepin MG; Weis M; Eyre DR; Walsh J; Lambert D; Green A; Robinson H; Michelson M; Houge G; Lindman C; Martin J; Ward J; Lemyre E; Mitchell JJ; Krakow D; Rimoin DL; Cohn DH; Byers PH; Lee B
Hum Mutat; 2008 Dec; 29(12):1435-42. PubMed ID: 18566967
[TBL] [Abstract][Full Text] [Related]
18. Cranial base abnormalities in osteogenesis imperfecta: phenotypic and genotypic determinants.
Cheung MS; Arponen H; Roughley P; Azouz ME; Glorieux FH; Waltimo-Sirén J; Rauch F
J Bone Miner Res; 2011 Feb; 26(2):405-13. PubMed ID: 20721936
[TBL] [Abstract][Full Text] [Related]
19. Prolyl 3-hydroxylase 1 and CRTAP are mutually stabilizing in the endoplasmic reticulum collagen prolyl 3-hydroxylation complex.
Chang W; Barnes AM; Cabral WA; Bodurtha JN; Marini JC
Hum Mol Genet; 2010 Jan; 19(2):223-34. PubMed ID: 19846465
[TBL] [Abstract][Full Text] [Related]
20. CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta.
Morello R; Bertin TK; Chen Y; Hicks J; Tonachini L; Monticone M; Castagnola P; Rauch F; Glorieux FH; Vranka J; Bächinger HP; Pace JM; Schwarze U; Byers PH; Weis M; Fernandes RJ; Eyre DR; Yao Z; Boyce BF; Lee B
Cell; 2006 Oct; 127(2):291-304. PubMed ID: 17055431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
